Source: BMC Gastroenterology. Unidades: FM, FCF
Subjects: PROBIÓTICOS, ÚLCERA PÉPTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAVARRO-RODRIGUEZ, Tomás et al. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. BMC Gastroenterology, v. 13, p. 1-8 art. 56, 2013Tradução . . Disponível em: https://doi.org/10.1186/1471-230X-13-56. Acesso em: 23 ago. 2024.APA
Navarro-Rodriguez, T., Silva, F. M., Barbuti, R. C., Mattar, R., Moraes Filho, J. P. P. de, Oliveira, M. N. de, et al. (2013). Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. BMC Gastroenterology, 13, 1-8 art. 56. doi:10.1186/1471-230X-13-56NLM
Navarro-Rodriguez T, Silva FM, Barbuti RC, Mattar R, Moraes Filho JPP de, Oliveira MN de, Bogsan CSB, Chinzon D, Eisig JN. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study [Internet]. BMC Gastroenterology. 2013 ; 13 1-8 art. 56.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1186/1471-230X-13-56Vancouver
Navarro-Rodriguez T, Silva FM, Barbuti RC, Mattar R, Moraes Filho JPP de, Oliveira MN de, Bogsan CSB, Chinzon D, Eisig JN. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study [Internet]. BMC Gastroenterology. 2013 ; 13 1-8 art. 56.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1186/1471-230X-13-56